Clinical Trial Update: A Long-term Study to Monitor the Health Status of People With Cystic Fibrosis Who Took Part in a Previous Study With BI 3720931 (Lenticlair™-ON) [Phase 1, Phase 2]

View source ↗

Summary

A long-term follow-up study to monitor health status in people with cystic fibrosis who previously participated in a Boehringer Ingelheim trial of BI-3720931 (L…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Drugs mentioned

• Lenticlair (BI 3720931)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Cystic Fibrosis | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING